Sean C.  Flynn net worth and biography

Sean Flynn Biography and Net Worth

VP of Vericel
Sean joined Vericel in 2019, having served as corporate and litigation counsel for nearly 20 years in both the public and private sectors.  Prior to joining Vericel, Sean held the position of Vice President and General Counsel of Verastem, Inc. where he was responsible for all legal matters and supported the launch and commercialization of Copiktra®.  Sean also served as Associate General Counsel and Chief Compliance Officer for ABIOMED, Inc. during a period of rapid revenue and market growth.  In that capacity, Sean handled a wide variety of business and legal matters for the organization, while maintaining responsibility for the compliance readiness of the company on a global scale.  Prior to joining ABIOMED, Sean served for seven years as a federal prosecutor with the Offices of the United States Attorney for the Eastern District of California and the Eastern District of New York.  Sean began his legal career as a litigator with Bingham McCutchen LLP, after clerking for the Honorable Ruggero J. Aldisert, Senior Circuit Judge, United States Court of Appeals for the Third Circuit.  Prior to beginning his legal career, Sean served as an Air Defense Artillery Officer in the United States Army, having graduated from the United States Military Academy at West Point in 1995.

What is Sean C. Flynn's net worth?

The estimated net worth of Sean C. Flynn is at least $41,175.68 as of July 16th, 2024. Mr. Flynn owns 707 shares of Vericel stock worth more than $41,176 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Flynn may own. Additionally, Mr. Flynn receives a salary of $657,010.00 as VP at Vericel. Learn More about Sean C. Flynn's net worth.

How old is Sean C. Flynn?

Mr. Flynn is currently 50 years old. There are 4 older executives and no younger executives at Vericel. The oldest executive at Vericel is Mr. Michael Halpin, Chief Operating Officer, who is 62 years old. Learn More on Sean C. Flynn's age.

What is Sean C. Flynn's salary?

As the VP of Vericel Co., Mr. Flynn earns $657,010.00 per year. There are 4 executives that earn more than Mr. Flynn. The highest earning executive at Vericel is Mr. Dominick C. Colangelo Esq., CEO, President & Director, who commands a salary of $1,540,000.00 per year. Learn More on Sean C. Flynn's salary.

How do I contact Sean C. Flynn?

The corporate mailing address for Mr. Flynn and other Vericel executives is 64 SIDNEY STREET, CAMBRIDGE MA, 02139. Vericel can also be reached via phone at (617) 588-5555 and via email at [email protected]. Learn More on Sean C. Flynn's contact information.

Has Sean C. Flynn been buying or selling shares of Vericel?

Sean C. Flynn has not been actively trading shares of Vericel within the last three months. Most recently, Sean C. Flynn sold 15,000 shares of the business's stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $52.18, for a transaction totalling $782,700.00. Following the completion of the sale, the insider now directly owns 707 shares of the company's stock, valued at $36,891.26. Learn More on Sean C. Flynn's trading history.

Who are Vericel's active insiders?

Vericel's insider roster includes Sean Flynn (VP), Steven Gilman (Director), Michael Halpin (COO), Jonathan Hopper (Insider), and Paul Wotton (Director). Learn More on Vericel's active insiders.

Are insiders buying or selling shares of Vericel?

During the last year, insiders at the biotechnology company sold shares 22 times. They sold a total of 189,150 shares worth more than $8,664,626.06. The most recent insider tranaction occured on December, 2nd when insider Jonathan Mark Hopper sold 10,000 shares worth more than $587,200.00. Insiders at Vericel own 7.2% of the company. Learn More about insider trades at Vericel.

Information on this page was last updated on 12/2/2024.

Sean C. Flynn Insider Trading History at Vericel

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/16/2024Sell15,000$52.18$782,700.00707View SEC Filing Icon  
6/24/2024Sell1,474$45.84$67,568.16487View SEC Filing Icon  
6/21/2024Sell6,772$45.02$304,875.44487View SEC Filing Icon  
3/8/2024Sell8,115$45.33$367,852.95167View SEC Filing Icon  
7/21/2021Sell2,800$55.01$154,028.00View SEC Filing Icon  
7/15/2021Sell10,000$51.18$511,800.00View SEC Filing Icon  
See Full Table

Sean C. Flynn Buying and Selling Activity at Vericel

This chart shows Sean C Flynn's buying and selling at Vericel by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vericel Company Overview

Vericel logo
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Read More

Today's Range

Now: $58.24
Low: $56.90
High: $59.42

50 Day Range

MA: $47.87
Low: $40.05
High: $59.11

2 Week Range

Now: $58.24
Low: $32.31
High: $61.49

Volume

420,199 shs

Average Volume

458,479 shs

Market Capitalization

$2.87 billion

P/E Ratio

970.83

Dividend Yield

N/A

Beta

1.71